Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Spatial Inequities in COVID-19 outcomes in 3 US Cities

View ORCID ProfileUsama Bilal, View ORCID ProfileSharrelle Barber, View ORCID ProfileAna V. Diez-Roux
doi: https://doi.org/10.1101/2020.05.01.20087833
Usama Bilal
1- Urban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA
2- Department of Epidemiology and Biostatistics, Drexel Dornsife School of Public Health, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Usama Bilal
  • For correspondence: ubilal{at}drexel.edu
Sharrelle Barber
1- Urban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA
2- Department of Epidemiology and Biostatistics, Drexel Dornsife School of Public Health, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sharrelle Barber
Ana V. Diez-Roux
1- Urban Health Collaborative, Drexel Dornsife School of Public Health, Philadelphia, PA
2- Department of Epidemiology and Biostatistics, Drexel Dornsife School of Public Health, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana V. Diez-Roux
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Preliminary evidence has shown wide inequities in COVID-19 related deaths in the US. We explored the emergence of spatial inequities in COVID-19 testing, positivity, and incidence in New York City, Philadelphia, and Chicago.

Methods We used zip code-level data on cumulative tests and confirmed cases by date for each city and computed testing, positivity, and incidence indicators. We linked these to 2014-2018 American Community Survey data on income, education, race/ethnicity, occupation, health insurance, and overcrowding, and computed a summary index. We computed associations between using Poisson models. We also examined clusters of high and low incidence using the G* statistic.

Results Through May 18th, there were wide inequities in positivity and incidence, with less advantaged neighborhoods having a higher incidence (RR=1.36 [95% CrI 1.18;1.57], 1.17 [1.11;1.23], and 1.10 [0.98;1.23], per 1 SD increase in the summary index in Chicago, NYC and Philadelphia, respectively). In all three cities inequities in incidence increased as the pandemic advanced, while inequities in positivity remained stable. In contrast the social patterning of testing changed over time: testing was inversely associated with disadvantage early in the pandemic but was either not associated or positively associated with disadvantage later in the pandemic. We also found clusters of high and low incidence, co-located with areas of high and low disadvantage.

Conclusions We found wide spatial inequities in COVID-19 positivity and incidence in three large metropolitan areas of the US. In health crises health inequities become magnified and reflect a longstanding history of racial and economic injustice.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

UB was supported by the Office of the Director of the National Institutes of Health under award number DP5OD26429. The funding agencies had no involvement in the study design; in the data collection, analyses or interpretation of data; in the writing of this work; or in the decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All data is publicly available and deidentified.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is publicly available. Code is available on a github repository.

https://github.com/usamabilal/COVID_Disparities

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Spatial Inequities in COVID-19 outcomes in 3 US Cities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Spatial Inequities in COVID-19 outcomes in 3 US Cities
Usama Bilal, Sharrelle Barber, Ana V. Diez-Roux
medRxiv 2020.05.01.20087833; doi: https://doi.org/10.1101/2020.05.01.20087833
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Spatial Inequities in COVID-19 outcomes in 3 US Cities
Usama Bilal, Sharrelle Barber, Ana V. Diez-Roux
medRxiv 2020.05.01.20087833; doi: https://doi.org/10.1101/2020.05.01.20087833

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14638)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)